title: Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.
abstract: The hematopoietic and non-hematopoietic stem/progenitor cells harvested directly from the bone marrow (BM) or G-CSF mobilized peripheral blood were demonstrated to play an important role in regeneration of damaged organs (1, 2). Here, we asked if the stroke- or acute heart infarct-related stress triggers mobilization of stem/progenitor-enriched CD34(+)cells from the BM into the peripheral blood, which subsequently could contribute to regeneration of damaged tissues. To address this question the peripheral blood samples were harvested from patients with ischemic stroke during the first 24 h of manifestation of symptoms and on the second and sixth day afterwards or during the first 24 h of acute cardiac pain as well as on the second and sixth day of infarct. We measured in these patients (i) percentage of circulating hematopoietic stem/progenitor-enriched CD34(+) cells in peripheral blood by employing fluorescence activated cell sorter (FACS) and (ii) number of hematopoietic progenitor cells for the granulocyte-monocytic colony-forming unit (CFU-GM) and erythoid burst-forming unit (BFU-E) lineages circulating in peripheral blood. We concluded that stress related to ischemic stroke or acute myocardial infarction triggers the mobilization of hematopoietic stem/progenitor-enriched CD34(+) cells from the BM into peripheral blood. These circulating stem/progenitor-enriched CD34(+) cells may contribute to the regeneration of ischemic tissues, however, this possibility requires further studies.
authors.affiliation: Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
authors.forename: E
authors.initials: E
authors.lastname: Paczkowska
authors.forename: B
authors.initials: B
authors.lastname: Larysz
authors.forename: R
authors.initials: R
authors.lastname: Rzeuski
authors.forename: A
authors.initials: A
authors.lastname: Karbicka
authors.forename: R
authors.initials: R
authors.lastname: Jałowiński
authors.forename: Z
authors.initials: Z
authors.lastname: Kornacewicz-Jach
authors.forename: M Z
authors.initials: MZ
authors.lastname: Ratajczak
authors.forename: B
authors.initials: B
authors.lastname: Machaliński
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018952:Antigens, CD34 / Q000378:metabolism; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D006801:Humans; D007958:Leukocyte Count / Q000379:methods; D008297:Male; D008875:Middle Aged; D023461:Myeloid Progenitor Cells / Q000378:metabolism; D009203:Myocardial Infarction / Q000097:blood / Q000503:physiopathology*; D012038:Regeneration; D013312:Stress, Physiological / Q000097:blood / Q000503:physiopathology; D020521:Stroke / Q000097:blood / Q000503:physiopathology*
chemical_list: D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor